Indraneel Mittra

6.1k total citations
84 papers, 2.6k citations indexed

About

Indraneel Mittra is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Indraneel Mittra has authored 84 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 30 papers in Cancer Research and 20 papers in Molecular Biology. Recurrent topics in Indraneel Mittra's work include Breast Cancer Treatment Studies (17 papers), Global Cancer Incidence and Screening (14 papers) and Cancer Genomics and Diagnostics (11 papers). Indraneel Mittra is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), Global Cancer Incidence and Screening (14 papers) and Cancer Genomics and Diagnostics (11 papers). Indraneel Mittra collaborates with scholars based in India, United Kingdom and United States. Indraneel Mittra's co-authors include Rajendra Badwe, Rohini Hawaldar, Sudeep Gupta, J.L. Hayward, Gauravi Mishra, Vani Parmar, S. Gupta, Jayant S. Vaidya, Nita Nair and Ashwini Budrukkar and has published in prestigious journals such as Nature, Cell and The Lancet.

In The Last Decade

Indraneel Mittra

82 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indraneel Mittra India 26 1.3k 872 457 441 345 84 2.6k
Sarah J. Nyante United States 23 1.2k 1.0× 1.1k 1.2× 556 1.2× 188 0.4× 350 1.0× 51 2.4k
Edward Azavedo Sweden 25 1.0k 0.8× 666 0.8× 201 0.4× 177 0.4× 522 1.5× 57 2.1k
William A. Knight United States 21 943 0.7× 675 0.8× 453 1.0× 396 0.9× 225 0.7× 68 2.5k
Adnan Ghafoor United States 2 1.5k 1.1× 512 0.6× 891 1.9× 282 0.6× 297 0.9× 3 3.2k
W. Lichtenegger Germany 35 1.8k 1.4× 1.1k 1.2× 1.0k 2.2× 312 0.7× 296 0.9× 243 4.6k
Giuseppe D’Aiuto Italy 28 1.4k 1.1× 1.2k 1.4× 697 1.5× 119 0.3× 334 1.0× 90 2.8k
Ellen G. Feigal United States 21 1.5k 1.2× 281 0.3× 735 1.6× 477 1.1× 478 1.4× 43 2.8k
Stefania Gori Italy 30 2.0k 1.6× 694 0.8× 680 1.5× 234 0.5× 299 0.9× 180 3.5k
Cinzia Orlandini Italy 29 2.2k 1.7× 630 0.7× 622 1.4× 345 0.8× 217 0.6× 74 3.7k
Lei Fan China 19 935 0.7× 622 0.7× 602 1.3× 165 0.4× 178 0.5× 57 2.2k

Countries citing papers authored by Indraneel Mittra

Since Specialization
Citations

This map shows the geographic impact of Indraneel Mittra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indraneel Mittra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indraneel Mittra more than expected).

Fields of papers citing papers by Indraneel Mittra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indraneel Mittra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indraneel Mittra. The network helps show where Indraneel Mittra may publish in the future.

Co-authorship network of co-authors of Indraneel Mittra

This figure shows the co-authorship network connecting the top 25 collaborators of Indraneel Mittra. A scholar is included among the top collaborators of Indraneel Mittra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indraneel Mittra. Indraneel Mittra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mittra, Indraneel, et al.. (2025). Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin. Pharmaceuticals. 18(1). 132–132. 2 indexed citations
2.
Raghuram, G., et al.. (2024). Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes. PLoS ONE. 19(2). e0298042–e0298042. 1 indexed citations
3.
Mittra, Indraneel. (2024). Exploiting the damaging effects of ROS for therapeutic use by deactivating cell-free chromatin: the alchemy of resveratrol and copper. Frontiers in Pharmacology. 15. 1345786–1345786. 4 indexed citations
4.
Raghuram, G., et al.. (2024). Cell-free chromatin particles released from dying cells inflict mitochondrial damage and ROS production in living cells. Cell Death Discovery. 10(1). 30–30. 7 indexed citations
5.
Raghuram, G., Sophiya Siddiqui, Naveen Kumar Khare, et al.. (2022). A pro-oxidant combination of resveratrol and copper down-regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer: Results of an exploratory study (RESCU 004). Frontiers in Oncology. 12. 1000957–1000957. 13 indexed citations
6.
Khandelwal, Aakanksha, Kavita Pal, Naveen Kumar Khare, et al.. (2022). A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001). PLoS ONE. 17(2). e0262212–e0262212. 17 indexed citations
7.
Pal, Kavita, et al.. (2021). A New Perspective on the Origin of DNA Double-Strand Breaks and Its Implications for Ageing. Genes. 12(2). 163–163. 8 indexed citations
8.
Raghuram, G., Pradip Chaudhari, Richa Pandey, et al.. (2018). Prevention of radiation-induced bystander effects by agents that inactivate cell-free chromatin released from irradiated dying cells. Cell Death and Disease. 9(12). 1142–1142. 37 indexed citations
9.
Jalali, Rakesh, Indraneel Mittra, & Rajendra Badwe. (2016). Cancer research: in need of introspection. The Lancet Oncology. 17(2). 140–141. 2 indexed citations
10.
Parmar, Vani, Rohini Hawaldar, Nita Nair, et al.. (2013). Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer. The Breast. 22(6). 1081–1086. 29 indexed citations
11.
Badwe, Rajendra, Rohini Hawaldar, Vani Parmar, et al.. (2011). Single-Injection Depot Progesterone Before Surgery and Survival in Women With Operable Breast Cancer: A Randomized Controlled Trial. Journal of Clinical Oncology. 29(21). 2845–2851. 52 indexed citations
12.
Mittra, Indraneel, et al.. (2010). Abstract LB-103: Circulating chromatin is a novel DNA damaging agent that induces genomic instability and malignant transformation. Cancer Research. 70(8_Supplement). LB–103. 2 indexed citations
13.
Gadallah, Mohsen, et al.. (2005). Breast screening in the emerging world: High prevalence of breast cancer in Cairo. The Breast. 14(5). 340–346. 56 indexed citations
14.
Mittra, Indraneel. (2000). Is clinical breast examination an acceptable alternative to mammographic screening?. BMJ. 321(7268). 1071–1073. 49 indexed citations
15.
Mittra, Indraneel, et al.. (2000). Timing of surgery during the menstrual cycle and prognosis of breast cancer. Journal of Biosciences. 25(1). 113–120. 13 indexed citations
16.
Vaidya, Jayant S. & Indraneel Mittra. (1997). Fraction of normal remaining life span: a new method for expressing survival in cancer. BMJ. 314(7095). 1682–1682. 4 indexed citations
17.
Mittra, Indraneel, et al.. (1995). Prognosis of breast cancer: Evidence for interaction between c‐erbB‐2 overexpression and number of involved axillary lymph nodes. Journal of Surgical Oncology. 60(2). 106–111. 24 indexed citations
18.
19.
Mittra, Indraneel, et al.. (1992). Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.. PubMed. 96. 1–8. 12 indexed citations
20.
Mittra, Indraneel, J Perrin, & S Kumaoka. (1976). Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer.. BMJ. 1(6004). 257–259. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah J. Nyante Breakdown of academic impact, for papers by Edward Azavedo Breakdown of academic impact, for papers by William A. Knight Breakdown of academic impact, for papers by Adnan Ghafoor Breakdown of academic impact, for papers by W. Lichtenegger Breakdown of academic impact, for papers by Giuseppe D’Aiuto Breakdown of academic impact, for papers by Ellen G. Feigal Breakdown of academic impact, for papers by Stefania Gori Breakdown of academic impact, for papers by Cinzia Orlandini Breakdown of academic impact, for papers by Lei Fan
Rankless by CCL
2026